SEC Form 4 · accession 0000899243-18-028722
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nader Pourhassan
Officer — President and CEO · Director
Period of report
Nov 8, 2018
Accepted (ET)
Nov 13, 2018 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.565 | Nov 8, 2018 | A | 1,000,000 | A | — | Nov 8, 2028 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1Fifty percent (50%) of the options were fully vested and exercisable as of the date of the reported transaction, and fifty percent (50%) of the options will vest on April 8, 2019.